| Tag | Content |
|---|
EnhancerAtlas ID | HS157-02496 |
Organism | Homo sapiens |
Tissue/cell | PANC-1 |
Coordinate | chr11:14401870-14403900 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr11:14403021-14403039 | GGAACGAAGGCAGGCGGG | + | 6.36 | | Foxd3 | MA0041.1 | chr11:14402054-14402066 | AAACAAACAAAC | - | 6.32 | | Zfx | MA0146.2 | chr11:14402886-14402900 | CCGGCCGGGGCCTG | + | 7.01 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_11122 | chr11:14402028-14403640 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr11 | 14403696 | 14403812 | | chr11 | 14402398 | 14403400 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH11I014380 | chr11 | 14402305 | 14403602 | | GH11I014382 | chr11 | 14403621 | 14403638 |
|
Enhancer Sequence | TTGGTGAAAA CCCGTCTCTC CTAAAAATAC AAAAATTAGC TGGGCTTCAT GGCACGCACC 60
TGTAATCCCA GCAACTCAGG AGGCTGAGGC AGGAGAGTCG CTTGAACCTG GGAGGCAGAG 120
GTTGCAGTGA GCCGAGATCA CACCAGTGCA CTCCAGCCTG GGCGACAGAG CAAGGCTCCG 180
TCTCAAACAA ACAAACAAAA AAAATCGTAT TGTAAAAGAA TATTGGTTGG TACAGAAAAT 240
GTTCATGATT TACTGCTAAG CAAAATACAA CAACAACAAA AAAAAACTTA CAAAATAATA 300
ACTACAACGT GACACCCTTT CTTTTGTACA GAGAATAAAG CATGCTATCA CAGGCATAAA 360
ATACTGAAGG GACAGATACT AACATGTTAA CAACAGTTGC TCTTGGGTTG CGAGGCAGGG 420
GTAGTTAGAA GAAATGTTTG TATTTTTCCT TTATACTATT TTGCTTTTTT CGTGTTTTCC 480
TACCTTGAGT ACCTTGTTTG CCTAATTAAA GAGGTGGGGA GAGGAGGAGA TTTCCTCTCC 540
CGCTTTTAAT TTTTTTTTTT TTTTAAAGAA AATCACGCTG ACTGTGTGCC TAGGAAACTA 600
TTGCCAGAAT TTCCAACATC TCCCACAGCC CGGTGCTTGG GGAAACCAGA ACTAAGTGAA 660
AGACTTTCTC TCTGAGAGCA AAGTGCGCAG GTGACAGGAG AGAAGGGCAG AGGAAAGAAA 720
TGGGTTGGAC CGATCCGAGA ACGGGCAGGC TGGCGTGCCG ACGGTCGCCA GCAGACAGCC 780
CTCTCCCTAG CGGAGCGCTC GCCCCAGCCT CTGCCCAGAA GGCCCGGGGC GACGCGCTCG 840
GATGCGTGGC TCCGGAAGGG CACTGAGCTA GAACATGCTG GGGCACCGCG CGGGCACCCA 900
GGTGCCGCTG GCGCCGCTGA CGAGGGGTGC TAGCAGGCTG TGCTCGAGGA GCTAGGAAGC 960
TGTAAGCCTG TGAAAAGCCA AGCCAACCAG GCAGAGCGGC TCCGCAACAG CTAGCCCCGG 1020
CCGGGGCCTG CCCAGCGCTG CGTTGACCGC CGGAGCCCGC GTGCCGCTGC AGCGGAGCCA 1080
TCATGAAGCG GCTCCCTGGC CAGGCCGTCC TGGCAGCCCG CCCGCCCCGC CCGCTGCGGA 1140
GCAGTGCCCG GGGAACGAAG GCAGGCGGGG ATCATGTGCT GCGCGCTCAG GAGCCCTTGG 1200
CATTCCTCGC GGGGCGGCAG CTCTCCCCTC CATTTCCACC CAGGGGGGCT ATCGGTCTTA 1260
CTTTAAAAAG ACAAAAACAC AAATTACGGT GACGCAAAAG AAATATAAAA ACAGGAGTCA 1320
GAGGACCTAG ATTTGATTGT CAACCCATGT GACCATGAGC AGGTCACATT CATGCCTCTG 1380
CTTCCCTATC TGTGACATGG ATATAATGAT CCTATTTGTC CCAAGAGGTA GCCGTGAGTC 1440
TTATTAATGA AGATACAAAT GATATAAGAG TAATGAAAAC TGCTTTGCAA ATTATGAAGG 1500
ATAAGCTGAT GCCAGTCCCT GTTCGCTAGA TGTATACATT TCAGGACTTC GTAGTTCTTT 1560
AATTTTGAAT GTTATTTGTG TGTATTGGTA AATCATCACT TTCCACTTTC CACAGTTTAA 1620
AATGGAAGAC TATAGTGCAG TGATAGCTTA GAACTGGGAA GGAAATCAGG TCCAAAGCAA 1680
AGGAGAGCAC ACACCTGCCA ATATAAAGAT CAATAACATT TCTGACACTG GGTTTGGAGT 1740
TGAGTTCTGA GTTTCACAGC AGTCAAAGTG TAAAAGGAAC CACGATCAGA TGTTGTACTC 1800
ATTATCAGAA AAGATTAGTA CAGAGGAGAA GGTTAAGCAA GACAAGTGCC CTCAGGAAAA 1860
AATGGGATGT TCTCTAAATC CGCATTCCCC AAGTATCAGT CGTTTACATA CCATCTTCAT 1920
GTGTTTTGCT GTATTTATAT GCCACATGTA CATTTAGTTA ACGAATATTT TTTCTTTAAA 1980
ACAGTCTAAC AAAAAATATT TCCTAATAAA AAATATATAT TACTCCCTTA 2030
|
